The SVS is excited to announce that the Vascular Surgery MIPS Value Pathway (MVP) has been posted for public comment with CMS. The Quality and Performance Measure Committee (QPMC) has worked diligently to develop a vascular specific MVP that reflects care of the vascular patient, applies to all practice types and locations, and is the least burdensome possible regarding data submission. The development of Vascular Surgery MVP is the first step in developing the specific, required quality metrics that improve vascular care. As the SVS awaits final CMS approval, the QPMC will continue to develop vascular specific quality measures with the intention to use in other CMS payment programs.
Dennis Gable, MD, Chair of the Quality Council, says, "Development of the vascular MVP championed by the SVS QPMC and supported by all committees reporting under the SVS Quality Council is a significant milestone in the ongoing dedication and goal by the SVS to further the quality of care for all vascular patients while also satisfying requirements for reporting data to CMS. As currently proposed, the vascular MVP design offers several quality metrics that are non-burdensome for physicians to report on while raising the bar for quality care of multiple separate vascular procedures."
The MVP pathway is the newest reporting option allowing clinicians to fulfill MIPS reporting requirements. MVPs are a subset of measures and activities that are related to a specialty or medical condition. Compared to traditional MIPS, MVPs require less, but more specialty-targeted measures to be reported, thereby reducing reporting burden. As a part of the Calendar Year 2025 Medicare Physician Fee Schedule Final Rule, CMS has committed to transitioning from traditional MIPS to MVP reporting by 2028.
The move from traditional MIPS reporting to MVPs is the next chapter in CMS’ efforts to facilitate clinicians’ move into Value Based Care models. The SVS QPMC and Quality Council have had productive dialogue with CMS during the development phase and look forward continuing our work towards MVP approval and maintenance going forward.
"There arise certain times when a medical specialty must unify and act to bring voice and change. This is such a time for members of the SVS to add their public comments in support of our Vascular Surgery MVP, and lead the way to developing the first of hopefully many vascular measures adopted by the CMS and developed by the SVS," stated Kenneth Slaw, SVS Executive Director.
The public comment period will be from Dec. 11 - Jan. 24, 2025.
Please send your comments to PIMMSMVPSupport@gdit.com.